GlassScriptPhysician profile
Charles Alan Hartranft
NPI 1235429705
$8,236.58
in general payments reported to CMS, 2019-2025
24 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,390 · 2020: $825 · 2021: $798 · 2022: $822 · 2023: $431 · 2024: $2,072 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,260 · Travel and Lodging: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,259.87 |
| Travel and Lodging | $1,142.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,444.07 | 2019-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Penumbra, INC. | $2,347.30 | 2019-2025 | Indigo System |
| Shockwave Medical, INC | $993.34 | 2022-2025 | |
| Endologix LLC | $636.89 | 2021-2024 | Endocross Device, Torus Stent Graft System |
| Smith+Nephew, INC. | $451.71 | 2022-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Silk Road Medical, INC. | $355.03 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $284.61 | 2021 | |
| Bard Peripheral Vascular, INC. | $202.11 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $136.63 | 2019 | |
| Abbott Laboratories | $100.70 | 2019 | |
| Solventum Corporation | $36.23 | 2024 | Activ.A.C. |
| Lemaitre Vascular, INC. | $33.67 | 2023-2025 | Hydro Lemaitre Valvulotome, Restoreflow |
| Janssen Pharmaceuticals, INC | $26.34 | 2019-2021 | |
| Bsn Medical INC | $24.67 | 2024 | |
| Cashflow Solutions, LLC | $24.28 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $23.75 | 2021 | |
| Organogenesis INC. | $17.34 | 2023 | Puraply |
| Medtronic Vascular, INC. | $16.29 | 2019 | |
| Access Pro Medical, LLC | $16.19 | 2025 | Matriderm |
| Elutia, INC. | $15.22 | 2021 | |
| Allergan, INC. | $14.50 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.15 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $11.67 | 2022 | |
| Kerecis Limited | $9.89 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hartranft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.